Welcome to our Blog! Jack Henry (JKHY) Quarterly Earnings Report Overview While the top- and bottom-line numbers for Jack Henry (JKHY) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values….
Welcome to Trisura Group Ltd. Exciting News Ahead! Trisura Group Ltd. Announces Q4 2024 Results Release We are thrilled to announce that Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU) will be releasing its fourth quarter and annual 2024 results in the coming days. As a leading specialty insurance provider, we are dedicated to…
Exciting News from Amazon’s Accelerate Seller Conference! Amazon Introduces New Enhancements for Merchants and Shoppers SEATTLE–(BUSINESS WIRE)–Today at Amazon’s Accelerate seller conference, Amazon (NASDAQ: AMZN) direct-to-customer (DTC) offerings, Buy with Prime and Amazon Multi-Channel Fulfillment (Amazon MCF), announced a number of enhancements to their merchant and shopper experiences. These new capabilities are part of Amazon’s…
All residents at 606 West 42nd Street Can Now Access Their Homes with Their iPhone or Apple Watch New York City, Dec. 18, 2024 Introduction: Silverstein Properties, along with SwiftConnect, Allegion, and Kastle, have announced a groundbreaking development for residents at 606 West 42nd Street in New York City. All residents at this multi-family housing…
Breaking News: Investors Affected by Integral Ad Science Holding Corp. Alleged Securities Fraud Have Opportunity to Join Class Action LOS ANGELES, March 13, 2025 The Law Offices of Frank R. Cruz, a leading securities litigation firm, announced today that investors who suffered losses in Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQ: IAS)…
The Impact of the FDA Decision on Eli Lilly’s Weight Loss Drug Background The Food and Drug Administration recently announced that the active ingredient in Eli Lilly’s weight loss drug Zepbound is no longer in shortage. This decision will have significant implications for both patients and compounding pharmacies. Transition Period During the 60 to 90-day…
Teva Pharmaceuticals and Alvotech Announce the Launch of SELARSDI™, a Biosimilar for the Treatment of Autoimmune Conditions in the U.S. On February 21, 2025, Teva Pharmaceuticals, a leading global pharmaceutical company, and Alvotech, a premier clinical-stage biotechnology company, announced the availability of SELARSDI™ (ustekinumab-aekn) injection in the United States. This biosimilar is an alternative to…
New Developments in CECO Environmental Corp Investigation Investors Beware: Pomerantz LLP Investigating Claims NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is currently conducting an investigation on behalf of investors of CECO Environmental Corp. (CECO) traded on NASDAQ under the symbol CECO. This investigation comes as a result of potential claims surrounding the Company’s…
